News Article

BetaStem Therapeutics Retains Conditas Biotechnology Group for Business Development and Corporate Strategy
Date: Jul 18, 2013
Source: Business Wire ( click here to go to the source)

Featured firm in this article: BetaStem Therapeutics Inc of Sausalito, CA



SAN FRANCISCO--(BUSINESS WIRE)--BetaStem Therapeutics, Inc., a pre-clinical biotechnology company focused on a curative treatment for diabetic retinopathy and diseases related to vascular damage, has retained Conditas Biotechnology Group, LLC for its services in the area of business development and corporate strategy.